Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
6.55
+0.24 (3.80%)
Feb 3, 2026, 4:00 PM EST - Market closed
Karyopharm Therapeutics Employees
Karyopharm Therapeutics had 279 employees as of December 31, 2024. The number of employees decreased by 46 or -14.15% compared to the previous year.
Employees
279
Change (1Y)
-46
Growth (1Y)
-14.15%
Revenue / Employee
$510,860
Profits / Employee
-$446,670
Market Cap
119.93M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 279 | -46 | -14.15% |
| Dec 31, 2023 | 325 | -60 | -15.58% |
| Dec 31, 2022 | 385 | -57 | -12.90% |
| Dec 31, 2021 | 442 | 10 | 2.31% |
| Dec 31, 2020 | 432 | 85 | 24.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 188 |
| Sutro Biopharma | 178 |
| Inovio Pharmaceuticals | 134 |
| Korro Bio | 87 |
| Verrica Pharmaceuticals | 71 |
| Cardiff Oncology | 33 |
| Spero Therapeutics | 32 |
| Genelux | 24 |
KPTI News
- 1 day ago - Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 22 days ago - Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026 - PRNewsWire
- 2 months ago - Karyopharm to Participate in Baird's Biotech Discovery Series - PRNewsWire
- 2 months ago - Karyopharm to Participate at the Piper Sandler 37th Annual Healthcare Conference - PRNewsWire
- 3 months ago - Karyopharm Therapeutics Inc. (KPTI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress - PRNewsWire
- 3 months ago - Karyopharm to Report Third Quarter 2025 Financial Results on November 3, 2025 - PRNewsWire
- 4 months ago - Karyopharm Strengthens Balance Sheet With $100 Million Financing To Extend Cash Runway Into 2026 - Benzinga